Drawing for VYGLEA

USPTO serial 87729233

VYGLEA

Reviewed by CopyMark Law Group

Reg. 7242841Status 700Registered
Filing date
Status date
Registration date
Dec 12, 2023
Examiner
KAJUBI, ELIZABETH N
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with VYGLEA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

Monica Riva Talley STERNE KESSLER GOLDSTEIN & FOX PLLC1100 NEW YORK AVE NW, SUITE 600WASHINGTON, DC 20005UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), frontotemporal dementia, cognitive impairment of aging, pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, chronic neuropathic pain, peripheral neuropathy, pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, Obsessive Compulsive Disorder (OCD), Generalized Anxiety Disorder (GAD), pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, adjunctive useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 12, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 12, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 8, 2023SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Nov 7, 2023CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 23, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 16, 2023IUAFUSE AMENDMENT FILED—
Aug 16, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 17, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 17, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 17, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 7, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 6, 2023EX5GSOU EXTENSION 5 GRANTED—
Mar 3, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 1, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Feb 17, 2023EXT5SOU EXTENSION 5 FILED—
Feb 17, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 15, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jan 11, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 20, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 18, 2022EX4GSOU EXTENSION 4 GRANTED—
Aug 18, 2022EXT4SOU EXTENSION 4 FILED—
Aug 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 18, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 16, 2022EX3GSOU EXTENSION 3 GRANTED—
Feb 16, 2022EXT3SOU EXTENSION 3 FILED—
Feb 16, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 14, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2021EX2GSOU EXTENSION 2 GRANTED—
Aug 12, 2021EXT2SOU EXTENSION 2 FILED—
Aug 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 12, 2021EX1GSOU EXTENSION 1 GRANTED—
Feb 12, 2021EXT1SOU EXTENSION 1 FILED—
Feb 12, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 18, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 9, 2020TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jul 9, 2020OP.TOPPOSITION TERMINATED NO. 999999—
Jul 9, 2020OP.DOPPOSITION DISMISSED NO. 999999—
Jun 10, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 23, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 27, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 28, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 30, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 30, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 10, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 21, 2018ALIEASSIGNED TO LIE—
Sep 6, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 30, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2018DOCKASSIGNED TO EXAMINER—
Jan 8, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 23, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance